Annual Accounts Payable
$827.00 K
-$1.12 M-57.55%
31 December 2023
Summary:
Enlivex Therapeutics annual accounts payable is currently $827.00 thousand, with the most recent change of -$1.12 million (-57.55%) on 31 December 2023. During the last 3 years, it has risen by +$364.00 thousand (+78.62%). ENLV annual accounts payable is now -57.55% below its all-time high of $1.95 million, reached on 31 December 2022.ENLV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$303.00 K
-$340.00 K-52.88%
30 June 2024
Summary:
Enlivex Therapeutics quarterly accounts payable is currently $303.00 thousand, with the most recent change of -$340.00 thousand (-52.88%) on 30 June 2024. Over the past year, it has dropped by -$491.00 thousand (-61.84%). ENLV quarterly accounts payable is now -84.45% below its all-time high of $1.95 million, reached on 31 December 2022.ENLV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -57.5% | -61.8% |
| 3 y3 years | +78.6% | -71.5% |
| 5 y5 years | +378.0% | +121.2% |
ENLV Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -57.5% | +78.6% | -84.5% | at low |
| 5 y | 5 years | -57.5% | +378.0% | -84.5% | +121.2% |
| alltime | all time | -57.5% | +4252.6% | -84.5% | +2230.8% |
Enlivex Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $303.00 K(-52.9%) |
| Mar 2024 | - | $643.00 K(-22.2%) |
| Dec 2023 | $827.00 K(-57.5%) | $827.00 K(+4.2%) |
| Sept 2023 | - | $794.00 K(-48.9%) |
| June 2023 | - | $1.55 M(+4.8%) |
| Mar 2023 | - | $1.48 M(-23.9%) |
| Dec 2022 | $1.95 M(+121.9%) | $1.95 M(+84.5%) |
| Sept 2022 | - | $1.06 M(+58.3%) |
| June 2022 | - | $667.00 K(-50.9%) |
| Mar 2022 | - | $1.36 M(+54.7%) |
| Dec 2021 | $878.00 K(+89.6%) | $878.00 K(-17.3%) |
| Sept 2021 | - | $1.06 M(+90.3%) |
| June 2021 | - | $558.00 K(+60.8%) |
| Mar 2021 | - | $347.00 K(-25.1%) |
| Dec 2020 | $463.00 K(+46.5%) | $463.00 K(+38.6%) |
| Sept 2020 | - | $334.00 K(-36.3%) |
| June 2020 | - | $524.00 K(+150.7%) |
| Mar 2020 | - | $209.00 K(-33.9%) |
| Dec 2019 | $316.00 K | $316.00 K(+130.7%) |
| Sept 2019 | - | $137.00 K(-57.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $321.00 K(+15.1%) |
| Mar 2019 | - | $279.00 K(+61.3%) |
| Dec 2018 | $173.00 K(+810.5%) | $173.00 K(+1230.8%) |
| June 2018 | - | $13.00 K(-31.6%) |
| Dec 2017 | $19.00 K(-97.3%) | $19.00 K(-73.6%) |
| Sept 2017 | - | $72.00 K(-19.1%) |
| June 2017 | - | $89.00 K(-83.6%) |
| Mar 2017 | - | $543.00 K(-22.4%) |
| Dec 2016 | $700.00 K(-50.4%) | $700.00 K(+797.4%) |
| Sept 2016 | - | $78.00 K(-87.4%) |
| June 2016 | - | $619.00 K(-37.0%) |
| Mar 2016 | - | $983.00 K(-30.4%) |
| Dec 2015 | $1.41 M(+9.9%) | $1.41 M(+75.0%) |
| Sept 2015 | - | $807.00 K(+6.0%) |
| June 2015 | - | $761.00 K(-5.7%) |
| Mar 2015 | - | $807.00 K(-37.2%) |
| Dec 2014 | $1.28 M(+2693.5%) | $1.28 M(+80.2%) |
| Sept 2014 | - | $713.00 K(+157.4%) |
| June 2014 | - | $277.00 K(+502.2%) |
| Dec 2013 | $46.00 K(-37.8%) | $46.00 K |
| Dec 2012 | $74.00 K | - |
FAQ
- What is Enlivex Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual accounts payable year-on-year change?
- What is Enlivex Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly accounts payable year-on-year change?
What is Enlivex Therapeutics annual accounts payable?
The current annual accounts payable of ENLV is $827.00 K
What is the all time high annual accounts payable for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual accounts payable is $1.95 M
What is Enlivex Therapeutics annual accounts payable year-on-year change?
Over the past year, ENLV annual accounts payable has changed by -$1.12 M (-57.55%)
What is Enlivex Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ENLV is $303.00 K
What is the all time high quarterly accounts payable for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly accounts payable is $1.95 M
What is Enlivex Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ENLV quarterly accounts payable has changed by -$491.00 K (-61.84%)